Bartolome Burguera MD
Diabetes, Lipid Metabolism
Director of Obesity Programs Endocrinology Institute Cleveland Clinic
Join to View Full Profile
9500 Euclid AveCleveland Clinic. Department Of EndocrinologyCleveland, OH 44195
Phone+1 216-445-8645
Dr. Burguera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 1994 - 1996
Pontificia Universidad Catolica de ChileClass of 1986
Certifications & Licensure
OH State Medical License 2013 - 2025
PA State Medical License 2000 - 2004
MN State Medical License 1996 - 2001
Publications & Presentations
PubMed
- Weight gain following an employer-based randomized trial evaluating the treatment of obesity with and without anti-obesity medication.Noura Nachawi, Marcio L Griebeler, Huijun Xiao, James Bena, Kevin M Pantalone
Obesity Research & Clinical Practice. 2025-03-02 - 1 citationsSafety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.Robert F Kushner, Donna H Ryan, John Deanfield, Alexander Kokkinos, Cintia Cercato
Obesity. 2025-03-01 - De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: ...Paloma Rodriguez, Nikki Breslaw, Huijun Xiao, Jim Bena, Kimberly Jenkins
Diabetes, Obesity & Metabolism. 2025-02-01
Press Mentions
Study Shows Bariatric Surgery Provides Superior Long-Term Treatment for Type 2 Diabetes in Patients with ObesityFebruary 27th, 2024- Long COVID-19 Among Patients with Obesity ‘May Be Missed or Misdiagnosed’September 17th, 2021
- Access to Obesity Medications Boosts Weight Loss in Employer-Based ProgramAugust 4th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
